Wall Street analysts expect Aveanna Healthcare (AVAH) to post quarterly earnings of $0.17 per share in its upcoming report, which indicates a year-over-year decline of 5.6%. Revenues are expected to be $647.08 million, up 9.8% from the year-ago quarter.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
In light of this perspective, let's dive into the average estimates of certain Aveanna metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts predict that the 'Revenue- PDS' will reach $530.01 million. The estimate indicates a change of +9.1% from the prior-year quarter.
Analysts expect 'Revenue- MS' to come in at $46.23 million. The estimate indicates a change of +6.4% from the prior-year quarter.
The combined assessment of analysts suggests that 'Revenue- HHH' will likely reach $65.79 million. The estimate suggests a change of +9.5% year over year.
Analysts forecast 'Hours - PDS' to reach 12099 hours. The estimate is in contrast to the year-ago figure of 11053 hours.
The average prediction of analysts places 'Revenue rate - MS' at $488.94 . Compared to the present estimate, the company reported $477.24 in the same quarter last year.
It is projected by analysts that the 'Unique patients served (UPS) - MS' will reach 95 . The estimate is in contrast to the year-ago figure of 91 .
According to the collective judgment of analysts, 'Revenue rate - PDS' should come in at $43.81 . Compared to the current estimate, the company reported $43.97 in the same quarter of the previous year.
Over the past month, Aveanna shares have recorded returns of -2.2% versus the Zacks S&P 500 composite's +3.4% change. Based on its Zacks Rank #2 (Buy), AVAH will likely outperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Â
Originally published on zacks.com, part of the BLOX Digital Content Exchange.
Please disable your ad blocker, whitelist our site, or purchase a subscription
Sorry, an error occurred.
Already Subscribed!
Cancel anytime
Thank you .
Your account has been registered, and you are now logged in.
Check your email for details.
Submitting this form below will send a message to your email with a link to change your password.
An email message containing instructions on how to reset your password has been sent to the email address listed on your account.
No promotional rates found.
Secure & Encrypted
Thank you.
Your gift purchase was successful! Your purchase was successful, and you are now logged in.
| Rate: | |
| Begins: | |
| Transaction ID: |
A receipt was sent to your email.
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.